MULTITUDE THERAPEUTICS
Multitude Therapeutics develops drugs for the treatment of tumors. It focuses on developing novel antibody-drug conjugates (ADC), CAR-Ts, and immuno-oncology antibodies for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer and immune cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart. The company was founded in 2018 and is based in Xuhui, Shanghai, China.
MULTITUDE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Xuhui, Shanghai, China
Country:
China
Website Url:
http://www.multitudetherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
0
Investors List
Northern Light Venture Capital
Northern Light Venture Capital investment in Venture Round - Multitude Therapeutics
Official Site Inspections
http://www.multitudetherapeutics.com
- Host name: 59.110.25.28
- IP address: 59.110.25.28
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
